SAWERA – Society for Appraisal & woman empowerment in rural areas

Email

sawera.nwfp@gmail.com

Phone

T: +92-937-840893

Web

www.sawera.pk

Address

House #113, street #05, sector Q Phase-II Shaiekh Malton Town Mardan 25000 Pakistan
About SAWERA – Society for Appraisal & woman empowerment in rural areas

About SAWERA
SAWERA is women leading NGO working in Federally Administrated Tribal Areas in particular and in KP in general. The inspiration behind the establishment of SAWERA is when some like-minded educated women of FATA to-gathered & think about the developmental interventions and feel that marginalized portion are repeatedly ignored by authorities.

The outcome of these deliberations and efforts was the creation of SAWERA in the year 2004. SAWERA is a voluntary not-for-profit organization dedicated to social & economic development with due regard for gender mainstreaming and social protection, specially focusing the backward areas & marginalized portion of the communities like women and children. The founding members have got rich experience in social engineering, participatory development, disaster management, gender mainstreaming and poverty alleviation initiatives through resource management in a systematic approach.

Working Area
SAWERA will work with women, men and children’s of each part of KP & FATA (Pakistan). While working with them, priority will be given towards most disadvantaged/marginalised groups of people i-e poor women, widows, people with disabilities and children. SAWERA also desire to support the vulnerable communities during disasters like war disaster, flood disasters and other emergency situation.

Vision:

"To develop a just society based on equality, indiscrimination, honor and dignity, peace & security for all and where individual are respected without status, tribe, ethnicity or religion".

Mission: 

"To help sustain grass roots institution and enable them to undertake their own development through effective institutional development and livelihood strategies".

Values:

In realising its aim and objectives, SAWERA will strive for:

  • Mutual respect and understanding
  • Equitability and impartiality
  • Participation and transparency
  • Partnership and cooperation,
  • Sincerity and
  • Self-confession (self-criticism, self-evaluation)

 

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close